Day: February 7, 2024
VONORE, Tenn., Feb. 07, 2024 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2024 second quarter ended December 31, 2023.
The highlights, commentary, and results provided herein relate to our continuing operations.
Highlights:Net sales for the second quarter was $99.5 million, down 37.5% from the prior-year period
Net income from continuing operations was $5.9 million, or $0.35 per diluted share
Diluted Adjusted Net Income per share, a non-GAAP measure, was $0.37, down 69.2% from the prior-year period
Adjusted EBITDA, a non-GAAP measure, was $9.8 million, down 67.2% from the prior-year period
Share repurchases of $4.4 million during the quarter
Ended the quarter with cash and investments of $108.8 millionFred Brightbill, Chief Executive Officer and Chairman,...
Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period
Written by Customer Service on . Posted in Public Companies.
Baltic Horizon Fund publishes interest rate applicable to the fund’s 5-year bonds (ISIN: EE3300003235) for the next 3-months interest period which starts on 8 February 2024. The annual interest rate applicable to the bonds for the interest period as referred above is 8% + 3.932% (EURIBOR 3-months) totaling 11.932% per annum.
For additional information, please contact:
Tarmo Karotam Baltic Horizon Fund manager E-mail tarmo.karotam@nh-cap.com www.baltichorizon.com
Baltic Horizon Fund is a registered contractual public closed-end real estate fund managed by Alternative Investment Fund Manager license holder Northern Horizon Capital AS.
Distribution: Nasdaq, GlobeNewswire, www.baltichorizon.com
To receive Nasdaq announcements and news from Baltic Horizon Fund about its projects, plans and more, register on www.baltichorizon.com. You can also...
Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period
Written by Customer Service on . Posted in Public Companies.
Baltic Horizon Fund publishes interest rate applicable to the fund’s 5-year bonds (ISIN: EE3300003235) for the next 3-months interest period which starts on 8 February 2024. The annual interest rate applicable to the bonds for the interest period as referred above is 8% + 3.932% (EURIBOR 3-months) totaling 11.932% per annum.
For additional information, please contact:
Tarmo Karotam Baltic Horizon Fund manager E-mail tarmo.karotam@nh-cap.com www.baltichorizon.com
Baltic Horizon Fund is a registered contractual public closed-end real estate fund managed by Alternative Investment Fund Manager license holder Northern Horizon Capital AS.
Distribution: Nasdaq, GlobeNewswire, www.baltichorizon.com
To receive Nasdaq announcements and news from Baltic Horizon Fund about its projects, plans and more, register on www.baltichorizon.com. You can also...
Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Written by Customer Service on . Posted in Public Companies.
SAN DIEGO, Feb. 07, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive management team will participate at the upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference on February 13-14 and conduct a virtual presentation. The virtual presentation will take place on Wednesday, February 14, 2024, at 12:40 pm ET.
A webcast of the presentation can be accessed under the “Events” tab on the investor relations section of the Belite Bio website at: https://investors.belitebio.com/presentations-events/events. The replay will be archived for 90 days following the presentation date.
About Belite...
Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Written by Customer Service on . Posted in Public Companies.
CAMBRIDGE, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1×1 investor meetings at the Oppenheimer 34th Annual Healthcare Life Sciences Conference.
Oppenheimer 34th Annual Healthcare Life Sciences Conference Fireside Chat: Wednesday, February 14, 2024 at 10:00 am ET Location: Virtual
A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.
About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media...
Infineon and Worksport collaborate to reduce weight and cost of portable power stations with GaN
Written by Customer Service on . Posted in Public Companies.
Munich, Germany and West Seneca, NY, USA, Feb. 07, 2024 (GLOBE NEWSWIRE) — Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) has announced a collaboration with Worksport Ltd. (Nasdaq: WKSP;). Worksport will use Infineon’s GaN power semiconductors GS-065-060-5-B-A in the converters for its portable power stations to increase efficiency and power density. Enabled by Infineon’s GaN transistors, the power converters will be lighter and smaller in size with reduced system costs. In addition, Infineon will support Worksport in the optimization of circuits and layout design to further reduce size and increase power density.
“Infineon’s high-quality standard and solid supply chain provide us with the best components to ensure power-dense converters for our COR system product line and contribute to a first-class end product performance,”...
Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™
Written by Customer Service on . Posted in Public Companies.
New data show additional improvement and stabilization in clinical outcomes in MPS II with 104 weeks of tividenofusp alfa (DNL310) treatment in the open-label, single-arm Phase 1/2 study; sustained normalization of CSF heparan sulfate and robust, sustained reduction in neurofilament light chain (NfL) observed
Announcing initiation of dosing with DNL126 (ETV:SGSH) in Phase 1/2 study in MPS IIIA and new supportive data with MPS IIIA mice showing reductions in heparan sulfate correlated with improvements in cognitive functionSOUTH SAN FRANCISCO, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for the treatment of neurodegenerative diseases and lysosomal storage diseases,...
Cheetah Net Supply Chain Service Inc. Completes Edward Acquisition
Written by Customer Service on . Posted in Mergers And Acquisitions.
CHARLOTTE, N.C., Feb. 07, 2024 (GLOBE NEWSWIRE) — Cheetah Net Supply Chain Service Inc. (“Cheetah” or the “Company”) (Nasdaq CM: CTNT) today announced the successful completion of its acquisition of Edward Transit Express Group Inc. (the “Acquisition”), a California-based global inbound non-vessel operating common carrier providing ocean and air transportation services (“Edward”). The Acquisition marks a pivotal achievement in Cheetah’s strategic expansion plans.
Tony Liu, Chairman and CEO, commented, “[t]he Acquisition positions us as a more visible competitor in our industry. This strategic move aligns seamlessly with our broader goals, strengthens our logistical capabilities, and enables us to provide end-to-end supply chain solutions. We are committed to leveraging the Acquisition by reducing transaction costs, creating new...
Interactive Strength Inc. (Nasdaq: TRNR) Completes Acquisition of CLMBR, Creating a High-growth, B2B Focused, Connected Fitness Platform
Written by Customer Service on . Posted in Mergers And Acquisitions.
The combined business is anticipated to generate between $15 million and $20 million in revenue in 2024, driven primarily by B2B sales to gyms, fitness studios and multi-family residential
Equipment sales are expected to be largely generated by distributors, including WOODWAY, with minimal marketing expenditure
The business is anticipated to be cashflow positive and adjusted EBITDA profitable potentially as early as the fourth quarter of 2024AUSTIN, TX, Feb. 07, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Interactive Strength Inc. (Nasdaq: TRNR) (“TRNR” or “the Company”), maker of premium smart home gyms and provider of virtual personal training services under the FORME brand, today announced that it has completed the acquisition of substantially all of the assets of CLMBR, Inc., (“CLMBR”) the maker of the first-to-market connected...
RBio Energy Corporation to Become a Public Company through a Business Combination with Perception Capital Corp. III
Written by Customer Service on . Posted in Mergers And Acquisitions.
Transaction expected to catalyze RBio Energy’s planned development of biorefinery assets and biomass and biogas power generation capacity
RBio Energy to grow platform through expected acquisitions
Merger anticipated to close in second quarter 2024; combined company anticipated to list on the Nasdaq Stock Market
ABERDEEN, Wash. and NEW YORK, Feb. 07, 2024 (GLOBE NEWSWIRE) — RBio Energy Corporation, which plans to develop clean energy projects (“RBio Energy”) and Perception Capital Corp. III., a special purpose acquisition company (Nasdaq: PFTA, PFTAW and PFTAU) (“Perception”), today announced they have entered into a definitive business combination agreement that would result in RBio Energy becoming a publicly traded company (the “Transaction”). Perception currently has over $42 million of cash in the trust account established...